Effect of Discharge Via an Intermediate Care Unit

Sponsor

Norwegian University of Science and Technology (Other)

Overall Status

Completed

CT.gov ID

NCT01706744

Collaborator

(none)

328

Enrollment

Locations

Arms

Duration (Months)

Patients Per Site

1.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The main goal is to investigate the following topics:

Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital?
Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital?
Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.

Condition or Disease	Intervention/Treatment	Phase
Patients Aged	Other: Intermediate care unit Other: Local health care 1 Other: Local health care 2	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

328 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study

Study Start Date :

Feb 1, 2010

Actual Primary Completion Date :

Dec 1, 2013

Actual Study Completion Date :

Dec 1, 2013

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Intermediate care unit Follow-up treatment and care in a intermediate care unit after discharge from hospital	Other: Intermediate care unit
Active Comparator: Local health care 1 Discharge from hospital to usual care as provided by the local health and social care (Verdal)	Other: Local health care 1
Active Comparator: Local health care 2 Discharge from hospital to usual care as provided by the local health and social care (Stjørdal)	Other: Local health care 2

Arm

Intervention/Treatment

Experimental: Intermediate care unit

Follow-up treatment and care in a intermediate care unit after discharge from hospital

Other: Intermediate care unit

Active Comparator: Local health care 1

Discharge from hospital to usual care as provided by the local health and social care (Verdal)

Other: Local health care 1

Active Comparator: Local health care 2

Discharge from hospital to usual care as provided by the local health and social care (Stjørdal)

Other: Local health care 2

Outcome Measures

Primary Outcome Measures

Hospital readmission [30 days]
Acute admission to hospital within 30 days from previous discharge
Use of local health care services [up to 1 year]

Secondary Outcome Measures

death [up to 1 year]
hospital admission [up to 1 year]
functional assessment status [up to 6 months]
Health service cost [up to 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:

60 Years to 99 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients 60 years old or older from Stjørdal- or Verdal municipality,

given consent,
admitted from their home,
diagnostics completed and necessary treatment started
the patient need not less than 3-4 days institutionalization for treatment/rehabilitation/care

Exclusion Criteria:

Patients with severe dementia
Patients with severe disease who cannot give consent
Patients with severe disease with short life expectancy (including severe cancer)

Contacts and Locations

Locations

	Site	City	Country
1	Sykehuset Levanger	Levanger	Norway
2	Distriksmedisinsk Senter	Stjørdal	Norway
3	Stjørdal Kommune	Stjørdal	Norway
4	Verdal kommune	Verdal	Norway

Sponsors and Collaborators

Norwegian University of Science and Technology

Investigators

Study Director: Roar Johnsen, PhD, Norwegian University of Science and Technology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Norwegian University of Science and Technology

ClinicalTrials.gov Identifier:

NCT01706744

Other Study ID Numbers:

2009/1697

First Posted:

Oct 15, 2012

Last Update Posted:

Dec 8, 2015

Last Verified:

Dec 1, 2015

Keywords provided by Norwegian University of Science and Technology

Hospital Readmissions

Community Health Services

Preventive Health Services

Norway

Study Results

No Results Posted as of Dec 8, 2015